0005 000520 28 Dec 2022 | Other | ₩80 Per Share |
0005 000520 29 Dec 2021 | Other | ₩72.73 Per Share |
0005 000520 29 Dec 2020 | Other | ₩68.18 Per Share |
0005 000520 27 Dec 2019 | Other | ₩68.18 Per Share |
0005 000520 27 Dec 2018 | Other | ₩45.45 Per Share |
15 May 2025 Date | | - Cons. EPS | - EPS |
13 Mar 2025 Date | | - Cons. EPS | - EPS |
13 Nov 2024 Date | | - Cons. EPS | - EPS |
12 Aug 2024 Date | | - Cons. EPS | 21.19 EPS |
13 May 2024 Date | | - Cons. EPS | - EPS |
0005 000520 28 Dec 2022 | Other | ₩80 Per Share |
0005 000520 29 Dec 2021 | Other | ₩72.73 Per Share |
0005 000520 29 Dec 2020 | Other | ₩68.18 Per Share |
0005 000520 27 Dec 2019 | Other | ₩68.18 Per Share |
0005 000520 27 Dec 2018 | Other | ₩45.45 Per Share |
15 May 2025 Date | | - Cons. EPS | - EPS |
13 Mar 2025 Date | | - Cons. EPS | - EPS |
13 Nov 2024 Date | | - Cons. EPS | - EPS |
12 Aug 2024 Date | | - Cons. EPS | 21.19 EPS |
13 May 2024 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Kang Huh CEO | KRX SM Exchange | KR7000520007 ISIN |
South Korea Country | 583 Employees | - Last Dividend | 24 Mar 2023 Last Split | - IPO Date |
Samil Pharmaceutical Co., Ltd is a renowned entity in South Korea, specializing in the development, manufacture, and sale of a wide spectrum of pharmaceutical products. Founded in 1947 and headquartered in Seoul, this company has established itself as a pivotal player in the healthcare industry by providing an extensive range of medications. Samil Pharmaceutical caters to various therapeutic areas, including hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, and many others. Besides prescription medicines, it also offers a variety of over-the-counter (OTC) products and sanitary aids, adhering to the highest standards of quality and safety to improve patient care and contribute to the community's well-being.